Eli Lilly's Mounjaro Becomes the World's Best-Selling Drug
Eli Lilly's diabetes and obesity drug, Mounjaro, has become the world's best-selling drug, surpassing Merck's Keytruda. Mounjaro generated $8.66 billion in sales in Q1 2026, up from $3.84 billion a year ago, driven by strong demand in the U.S. and international markets, including China.
Topics: diabetes earnings Mounjaro obesity pharmaceuticals sales_growth Zepbound